ArQule, Inc.

ArQule, Inc.

ArQule, Inc.

Overview
Date Founded

1994

Headquarters

19 PRESIDENTIAL WAY, WOBURN, MA, 01801

Type of Company

Public

Employees (Worldwide)

36

Industries

Pharmaceuticals
Biotechnology

Company Description

ArQule, Inc. is a biopharmaceutical company. It engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA.

Contact Data
Trying to get in touch with decision makers at ArQule, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Operating Officer

Chief Medical Officer

Principal Accounting Officer

Senior Vice President, Program Management & Product Planning

Senior Director-Business Development

Clinical Operations Director

Senior Manager-Human Resources

Clinical Trial Manager

Board of Directors

Senior Vice President-Finance & Global Controller at Merck & Co., Inc.

Paths to ArQule, Inc.
Potential Connections via
Relationship Science
You
ArQule, Inc.
Owners & Shareholders
Details Hidden

Consonance Capital Management's (CCM) funds seek to deliver exceptional, uncorrelated risk adjusted returns. CCM seeks to meet this objective by focusing on investment opportunities in the publicly traded stocks of healthcare companies. The firm invests in all sub-sectors of the healthcare sector including healthcare information technology, managed care, pharmaceuticals, specialty pharmaceuticals, commercial stage biotechnology, healthcare facilities and services, medical devices and supplies, diagnostics and consumer-based healthcare companies.CCM believes the public healthcare market lends itself to an active long/short strategy. The firm focuses on creating long and short portfolios driven by the opportunity for absolute return and alpha creation. The funds also invest in other types of securities and may use a variety of investment techniques to generate profit and/or control risk. These may include participating in swaps, buying or selling futures contracts, purchasing and writing options and other derivative contracts, purchasing or selling debt instruments, and trading on margin by borrowing funds and pledging securities as collateral. CCM invests primarily in healthcare companies in the US, and on an opportunistic basis in the rest of the world.^

Details Hidden

Nantahala Capital Management seeks superior and consistent risk-adjusted returns through investments in equity, fixed-income and equity-derivative securities. The firm will, however, invest in other asset classes of securities as opportunities arise. Nantahala seeks to achieve their clients' objectives through value-oriented securities selection and disciplined risk management.

Details Hidden

OrbiMed Advisors focuses on investments in the global healthcare industry. They utilizes strategies based on evaluating pharmaceutical, biotechnology, medical device, healthcare services and other companies in the global healthcare sector. The instruments in which OrbiMed invests include US and non-US equities, both long and short, as well as privately placed securities, debt securities, royalty bonds and other royalty instruments, currencies, private investments in public equity securities (PIPEs), ETFs, index options, and derivatives (including swap agreements). The firm invests across the global healthcare industry, from seed-stage venture capital to large publicly-traded companies. Investments are made across three strategies: public equity, private equity, and royalty opportunities. OrbiMed Advisors manages a series of public equity funds, including long/short event-driven funds and closed-end investment trusts. They invest across all types of publicly-traded companies, from biopharmaceuticals to medical devices and healthcare services worldwide. OrbiMed's private equity strategy is broad and flexible, investing from start-ups through growth equity. OrbiMed is typically a lead investor, seeking to help build our portfolio companies. Their geographic focus includes North America, Asia, Europe and Israel. For Royal Opportunities strategy, OrbiMed provides commercial-stage healthcare companies with non-dilutive structured debt capital. Additionally, they can monetize royalty streams, providing valuable financing solutions to owners of intellectual property.

Recent Transactions
Details Hidden

Merck & Co., Inc., Merck Sharp & Dohme Corp. purchase ArQule, Inc.

Details Hidden

ArQule, Inc. issued USD Common Stock

Details Hidden

ArQule, Inc. issued USD Common Stock

Insider Transactions
Details Hidden
Details Hidden
Transaction Advisors
Auditor

Advised onArQule, Inc. issued USD Common Stock

Underwriter

Advised onArQule, Inc. issued USD Common Stock

Escrow Agent

Advised onArQule, Inc. issued USD Common Stock

Professional

Advised onArQule, Inc. issued USD Common Stock

Managing Director

Advised onArQule, Inc. issued USD Common Stock

Underwriter

Advised onArQule, Inc. issued USD Common Stock

Advisors & Consultants
Legal Advisor

Attorney at Arnold & Porter LLP

Legal Advisor

Former Partner at Arnold & Porter LLP

Clients

Basilea Pharmaceutica Ltd. is headquartered in Basel, Switzerland, and listed on the SIX Swiss Exchange (SIX:BSLN). Through its fully integrated research and development operations the company focuses on the development of innovative antibiotics, antifungals and oncology drugs, targeting the medical challenge of resistance and non-response to current treatment options.

Roivant Sciences Ltd. functions as a holding company whose subsidiaries operates as biopharmaceutical company which engages in development and commercialization of novel therapies in therapeutic area. The company is headquartered in Hamilton, Bermuda.

Key Stats and Financials As of 2018
Market Capitalization
$2.41B
Total Enterprise Value
Earnings Per Share
Revenue
$25.8M
EBITDA
$-13.6M
Non-Profit Donations & Grants
$1,000 - $2,499
2012
$1,000 - $2,499
2009
Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Pfizer, Inc. Pharmaceuticals - New York, NY

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by ArQule, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of ArQule, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and ArQule, Inc..